BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 27780922)

  • 1. Somatostatin receptor based PET/CT in patients with the suspicion of cardiac sarcoidosis: an initial comparison to cardiac MRI.
    Lapa C; Reiter T; Kircher M; Schirbel A; Werner RA; Pelzer T; Pizarro C; Skowasch D; Thomas L; Schlesinger-Irsch U; Thomas D; Bundschuh RA; Bauer WR; Gärtner FC
    Oncotarget; 2016 Nov; 7(47):77807-77814. PubMed ID: 27780922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging of myocardial inflammation with somatostatin receptor based PET/CT - A comparison to cardiac MRI.
    Lapa C; Reiter T; Li X; Werner RA; Samnick S; Jahns R; Buck AK; Ertl G; Bauer WR
    Int J Cardiol; 2015 Sep; 194():44-9. PubMed ID: 26005805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hybrid Magnetic Resonance Imaging and Positron Emission Tomography With Fluorodeoxyglucose to Diagnose Active Cardiac Sarcoidosis.
    Dweck MR; Abgral R; Trivieri MG; Robson PM; Karakatsanis N; Mani V; Palmisano A; Miller MA; Lala A; Chang HL; Sanz J; Contreras J; Narula J; Fuster V; Padilla M; Fayad ZA; Kovacic JC
    JACC Cardiovasc Imaging; 2018 Jan; 11(1):94-107. PubMed ID: 28624396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic accuracy and prognostic value of simultaneous hybrid 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging in cardiac sarcoidosis.
    Wicks EC; Menezes LJ; Barnes A; Mohiddin SA; Sekhri N; Porter JC; Booth HL; Garrett E; Patel RS; Pavlou M; Groves AM; Elliott PM
    Eur Heart J Cardiovasc Imaging; 2018 Jul; 19(7):757-767. PubMed ID: 29319785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility of somatostatin receptor-targeted imaging for detection of myocardial inflammation: A pilot study.
    Bravo PE; Bajaj N; Padera RF; Morgan V; Hainer J; Bibbo CF; Harrington M; Park MA; Hyun H; Robertson M; Lakdawala NK; Groarke J; Stewart GC; Dorbala S; Blankstein R; Di Carli MF
    J Nucl Cardiol; 2021 Jun; 28(3):1089-1099. PubMed ID: 31197742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of (18)F-fluorodeoxyglucose positron emission tomography (FDG PET) and cardiac magnetic resonance (CMR) in corticosteroid-naive patients with conduction system disease due to cardiac sarcoidosis.
    Ohira H; Birnie DH; Pena E; Bernick J; Mc Ardle B; Leung E; Wells GA; Yoshinaga K; Tsujino I; Sato T; Manabe O; Oyama-Manabe N; Nishimura M; Tamaki N; Dick A; Dennie C; Klein R; Renaud J; deKemp RA; Ruddy TD; Chow BJW; Davies R; Hessian R; Liu P; Beanlands RSB; Nery PB
    Eur J Nucl Med Mol Imaging; 2016 Feb; 43(2):259-269. PubMed ID: 26359191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular magnetic resonance imaging and clinical performance of somatostatin receptor positron emission tomography in cardiac sarcoidosis.
    Pizarro C; Kluenker F; Dabir D; Thomas D; Gaertner FC; Essler M; Grohé C; Nickenig G; Skowasch D
    ESC Heart Fail; 2018 Apr; 5(2):249-261. PubMed ID: 29231290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Same day comparison of PET/CT and PET/MR in patients with cardiac sarcoidosis.
    Wisenberg G; Thiessen JD; Pavlovsky W; Butler J; Wilk B; Prato FS
    J Nucl Cardiol; 2020 Dec; 27(6):2118-2129. PubMed ID: 30603887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of Myocardial 18F-FDG Uptake Through Prolonged High-Fat, High-Protein, and Very-Low-Carbohydrate Diet Before FDG-PET/CT for Evaluation of Patients With Suspected Cardiac Sarcoidosis.
    Lu Y; Grant C; Xie K; Sweiss NJ
    Clin Nucl Med; 2017 Feb; 42(2):88-94. PubMed ID: 27922863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of
    Kaushik P; Patel C; Gulati GS; Seth S; Parakh N; Randeep Guleria ; Kumar R; Gupta P; Bal C
    Ann Nucl Med; 2021 Sep; 35(9):1058-1065. PubMed ID: 34125376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The response of FDG uptake to immunosuppressive treatment on FDG PET/CT imaging for cardiac sarcoidosis.
    Ahmadian A; Pawar S; Govender P; Berman J; Ruberg FL; Miller EJ
    J Nucl Cardiol; 2017 Apr; 24(2):413-424. PubMed ID: 27457527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of heparin loading during an 18F-FDG PET/CT examination to search for cardiac sarcoidosis activity.
    Ito K; Morooka M; Okazaki O; Minaminoto R; Kubota K; Hiroe M
    Clin Nucl Med; 2013 Feb; 38(2):128-30. PubMed ID: 23334129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed contrast-enhanced computed tomography in patients with known or suspected cardiac sarcoidosis: A feasibility study.
    Aikawa T; Oyama-Manabe N; Naya M; Ohira H; Sugimoto A; Tsujino I; Obara M; Manabe O; Kudo K; Tsutsui H; Tamaki N
    Eur Radiol; 2017 Oct; 27(10):4054-4063. PubMed ID: 28382537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Image fusion between 18F-FDG PET and MRI in cardiac sarcoidosis: A case series.
    Zandieh S; Bernt R; Mirzaei S; Haller J; Hergan K
    J Nucl Cardiol; 2018 Aug; 25(4):1128-1134. PubMed ID: 27604109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of cardiac magnetic resonance imaging and fluorodeoxyglucose positron emission tomography in the assessment of cardiac sarcoidosis: Meta-analysis and systematic review.
    Adhaduk M; Paudel B; Khalid MU; Ashwath M; Mansour S; Liu K
    J Nucl Cardiol; 2023 Aug; 30(4):1574-1587. PubMed ID: 36443587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18-FDG-PET in a patient cohort suspected for cardiac sarcoidosis: Right ventricular uptake is associated with pathological uptake in mediastinal lymph nodes.
    Tuominen H; Haarala A; Tikkakoski A; Kähönen M; Nikus K; Sipilä K
    J Nucl Cardiol; 2020 Feb; 27(1):109-117. PubMed ID: 29721764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac metastases from neuroendocrine neoplasms: complementary role of SSTR PET/CT and cardiac MRI.
    Arnfield EG; Tam L; Pattison DA; Younger J; Chikatamarla VA; Wyld D; Burge M; McCormack L; Ladwa R; Ramsay S
    J Nucl Cardiol; 2023 Dec; 30(6):2676-2691. PubMed ID: 37587328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional myocardial damage and active inflammation in patients with cardiac sarcoidosis detected by non-invasive multi-modal imaging.
    Kataoka S; Momose M; Fukushima K; Serizawa N; Suzuki A; Kondo C; Abe K; Sakai S; Hagiwara N
    Ann Nucl Med; 2017 Feb; 31(2):135-143. PubMed ID: 27804054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of newly diagnosed sarcoidosis in patients with ventricular arrhythmias: a cardiac magnetic resonance and 18F-FDG cardiac PET study.
    Kebed KY; Carter SV; Flatley E; Ward RP; Moss JD; Appelbaum DE; Singh A; Lang RM; Tung R; Patel AR
    Int J Cardiovasc Imaging; 2021 Apr; 37(4):1361-1369. PubMed ID: 33225427
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.